KD Chem's consolidated revenue has been essentially flat across four years, at KRW 62.1bn (2022), KRW 59.1bn (2023), KRW 62.4bn (2024), and KRW 62.9bn (2025).
Operating profit improved from KRW 5.70bn (9.2% margin) in 2022 to KRW 6.25bn (10.6%) in 2023 and KRW 7.47bn (12.0%) in 2024, before easing to KRW 6.97bn (11.1%) in 2025.
Net income attributable to owners followed a different pattern, actually declining from KRW 8.16bn in 2022 (unusually high relative to the operating margin that year) to KRW 5.32bn in 2023, KRW 5.39bn in 2024, and KRW 3.51bn in 2025.
On a quarterly basis, 2025Q2 posted operating profit of KRW 1.91bn yet a net loss attributable to owners of KRW 1.12bn, suggesting a sizable non-operating loss that quarter.
Results then stabilized somewhat, with 2025Q3 operating profit of KRW 1.98bn and net profit of KRW 2.30bn, 2025Q4 operating profit of KRW 1.23bn and net profit of KRW 0.75bn, and 2026Q1 operating profit of KRW 1.98bn and net profit of KRW 0.93bn, before 2026Q2 saw operating profit ease to KRW 1.56bn while net profit jumped to KRW 4.43bn, again highlighting the outsized role of non-operating items.
Summing the most recent four quarters (2025Q3 through 2026Q2), operating profit totals roughly KRW 6.76bn while net income attributable to owners totals roughly KRW 8.42bn, with net income continuing to exceed operating profit.
This pattern indicates that the core stabilizer manufacturing and sales business maintains a relatively stable operating margin in the 9-12% range, while equity-method gains/losses and financial income/expense items are driving the direction of quarterly bottom-line results.
On the balance sheet, the debt ratio has stayed low, easing from 26.8% in 2022 to 24.8% in 2025, and operating cash flow improved from KRW 3.09bn in 2022 to KRW 6.51bn in 2025.